The potential role of radiation therapy in Bowen's disease: A review of the current literature

Reviews on Recent Clinical Trials

Volumn 7, Issue 1, 2012, Pages 42-46

  Anna, Zygogianni ^a   John, Kouvaris ^a   Maria, Tolia ^b   George, Kyrgias ^c   Ivelina, Beli ^b   Ioanna, Kantzou ^d   Georgia, Soulimioti ^b   Vassilis, Kouloulias ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF THESSALY   (Greece)

^d METAXA CANCER HOSPITAL   (Greece)

Author keywords

Bowen's disease; Cosmesis; Radiotherapy; Review; Toxicity

Indexed keywords

ARTICLE; BOWEN DISEASE; CANCER CONTROL; CANCER PATIENT; CANCER RECURRENCE; ESTHETICS; HUMAN; MORBIDITY; PATIENT CARE; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME;

BOWEN'S DISEASE; HUMANS; SKIN NEOPLASMS;

EID: 84857420947     PISSN: 15748871     EISSN: 18761038     Source Type: Journal    
DOI: 10.2174/157488712799363271     Document Type: Article

References (40)

1. Cox N, Eedy D and Morton C, Guidelines for management of Bowen's disease, British J Dermatol 1999; 141: 633-641.
2. Dupree M, Kiteley R and Weismantle K, et al. Radiation therapy for Bowen's disease: Lessons for lesions of the lower extremity, J Am Acad Dermatol 2001; 45: 401-404.
3. Mackenzie-Wood A, Kossard S and De Launey J, et al. Imiquimod 5% cream in the treatment of Bowen's disease, J Am Acad Dermatol 2001; 44: 462-470.
4. Stone N and Burge S, Bowen's disease of the leg treated with weekly pulses of 5% fluorouracil cream, Br J Dermatol 1999; 140: 987-988.
5. Fitzpatrick's dermatology in general medicine (7th ed.), Wolff K, Goldsmith L and Katz S, et al. Editors, McGraw-Hill 2008.
6. Leibovitch I, Huilgol S and Selva D, et al. Cutaneous squamous carcinoma in situ (Bowen's disease): treatment with mohs micro-graphic surgery, J Am Acad Dermatol 2005; 52: 997-1002.
7. Ongenae K, Van De Kerckhove M and Naeyaert J, Bowen's disease of the nail, Dermatology 2002; 204: 348-350.
8. Zaiac M and Weiss E, Mohs micrographic surgery of the nail unit and squamous cell carcinoma, Dermatol Surg 2001; 27: 246-251.
9. Peris K, Micantonio T and Fargnoli M, et al. Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma, J Am Acad Dermatol 2006; 55: 324-327.
10. Ibbotson S, An overview of topical photodynamic therapy in dermatology, Photodiagnosis and Photodynamic Therapy 2010; 7: 16-23.
11. Smits T, Van Laarhoven A.I. M and Staassen A, et al. Induction of protoporphyrin IX by aminolaevulinic acid in actinic keratosis, psoriasis and normal skin: preferential porphyrin enrichment in differentiated cells, Br J Dermatol 2009; 160: 849-857.
12. Cox N, Eedy D and Morton C, Guidelines for management of Bowen's disease: 2006 update, Br J Dermatol 2007; 156: 11-21.
13. Morton C, McKenna K and Rhodes L, et al. Guidelines for topical photodynamic therapy: update, Br J Dermatol 2008; 159: 1245-1266.
14. Braathen L, Szeimies R.-M and Basset-Seguin N, et al. Guidelines on the use of photodynamic therapy for non-melanoma skin cancer: an international consensus, J Am Acad Dermatol 2007; 56: 125-143.
15. Lehmann P, Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer, Br J Dermatol 2007; 156: 793-801.
16. Morton C, Whitehurst C and McColl J, et al. Photodynamic therapy for large or multiple patches of Bowen's disease and basal cell carcinoma, Arch Dermatol 2001; 137: 319-324.
17. Togsverd-Bo K, Haedersdal M and Wulf H, Photodynamic therapy for tumors on the eyelid margins, Arch Dermatol 2009; 145: 944-947.
18. Braathen L, Paredes B and Salsela O, et al. Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses, J Euro Acad Dermatol 2009; 23: 550-555.
19. Attilia S, Ibbotson S, How we treat Bowen's disease with topical photodynamic therapy in Dundee, Photodiagnosis and Photodynamic Therapy 2009; 6: 41-45.
20. Babilas P, Travnick R and Werner A, et al. Split-face study using two different light sources for topical PDT of actinic keratoses: non-inferiority of the LED system, J Dtsch Dermatol Gest 2008; 6: 25-32.
21. Gad F, Viau G, Boushira M, Bertrand R and Bissonnette R, Photodynamic therapy with 5-aminolevulinic acid induces apoptosis and caspase activation in malignant T cells, J Cutan Med Surg 2001; 5: 8-13.
22. Kuzelova K, Grebenova D, Pluskalova M, Marinov I and Hrkal Z, Early apoptotic features of K562 cell death induced by 5-aminolaevulinic acid-based photodynamic therapy, J Photochem Photobiol B 2004; 73: 67-78.
23. Morton C, Whitehurst C and Moseley H, et al. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease, Br J Dermatol 1996; 135: 766-771.
24. Salim A, Leman J and McColl J, et al. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease, Br J Dermatol 2003; 148: 539-543.
25. Morton C, Horn M and Leman J, et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or fluorouracil for treatment of squamous cell carcinoma in situ: results of a multicenter randomized trial, Arch Dermatol 2006; 142: 729-735.
26. Morton C, Campbell S and Gupta G, et al. Intraindividual, rightleft comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study, Br J Dermatol 2006; 155: 1029-1036.
27. Sotiriou E, Apalla Z and Maliamani F, et al. Intraindividual, rightleft comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities, J Euro Acad Dermatol 2009; 23: 1061-1065.
28. Cox N and Dyson P, Wound healing on the lower leg after radiotherapy or cryotherapy of Bowen's disease and other malignant skin lesions, Br J Dermatol 1995; 133: 60-65.
29. Caccialanza M, Piccinno R and Beretta M, et al. Results and side effects of dermatologic radiotherapy: A retrospective study of irradiated cutaneous epithelial neoplasms, J Am Acad Dermatol 1999; 41: 589-594.
30. Herman JM, Pierce LJ, Sandler HM, Griffith KA, Jabbari S, Hiniker SM, Johnson TM. Radiotherapy using a water bath in the treatment of Bowen's disease of the digit. Radiotherapy and Oncology 2008; 88: 398-402.
31. Clinical radiation oncology (1st ed.), Gunderson L and Tepper J, Editors, Churchill Linvingstone, Philadelphia, PA 2000.
32. Radiobiology for the radiologist, Hall E, Editor, Lippincott Williams and Wilkins, Philadelphia, PA 2000.
33. The physics of radiation therapy (5th ed.), Khan F, Editor, Lippincott Williams and Wilkins, Philadelphia, PA 2003.
34. Dupree M, Kiteley R and Weismantle K, et al. Radiation therapy for Bowen's disease: lessons for lesions of the lower extremity, J Am Acad Dermatol 2001; 45: 401-404.
35. Herman J, Sandler H and Johnson T, et al. Radiotherapy is an efficacious option for Bowen's disease, Int J Radiat Oncol Biol Phys 2004; 60: p. S574.
36. Rayner C, The results of treatment of two hundred and seventythree carcinomas of the hand. Hand 1981; 13: 183-186.
37. Cox NH, Dyson P. Wound healing on the lower leg after radiotherapy or cryotherapy of Bowen's disease and other malignant skin lesions. Br J Dermatol 1995; 133: 60-5.
38. Chung YL, Lee JD, Bang D et al. Treatment of Bowen's disease with a specially designed radioactive skin patch. Eur J Nucl Med 2000; 27: 842-6.
39. Papillon J, Chassard JL. Respective roles of radiotherapy and surgery in the management of epidermoid carcinoma of the anal margin. Dis Colon Rectum 1992; 35: 422-9.
40. Hiruma M, Kawada A, Hyperthermic treatment of Bowen disease with disponsablechemical pocket warmers: a report of 8 cases. J Am Acad Dermatol 2000; 43: 1070-5.